Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 245

The DOI matches its Crossref record.

Accuracy of Physical Examination, Ultrasonography, and Mammography in Predicting Residual Pathologic Tumor Size in Patients Treated With Neoadjuvant Chemotherapy

Open access
Chagpar, Anees B., Middleton, Lavinia P., Sahin, Aysegul A., Dempsey, Peter, Buzdar, Aman U., Mirza, Attiqa N., Ames, Fredrick C., Babiera, Gildy V., Feig, Barry W., Hunt, Kelly K., Kuerer, Henry M., Meric-Bernstam, Funda, Ross, Merrick I., Singletary, S Eva · 2006 · Annals of Surgery

Abstract

In Brief Objective: To assess the accuracy of physical examination, ultrasonography, and mammography in predicting residual size of breast tumors following neoadjuvant chemotherapy. Background: Neoadjuvant chemotherapy is an accepted part of the management of stage II and III breast cancer. Accurate prediction of residual pathologic tumor size after neoadjuvant chemotherapy is critical in guiding surgical therapy. Although physical examination, ultrasonography, and mammography have all been used to predict residual tumor size, there have been conflicting reports about the accuracy of these methods in the neoadjuvant setting. Methods: We reviewed the records of 189 patients who participated in 1 of 2 protocols using doxorubicin-containing neoadjuvant chemotherapy, and who had assessment by physical examination, ultrasonography, and/or mammography no more than 60 days before their surgical resection. Size correlations were performed using Spearman rho analysis. Clinical and pathologic measurements were also compared categorically using the weighted kappa statistic. Results: Size estimates by physical examination, ultrasonography, and mammography were only moderately correlated with residual pathologic tumor size after neoadjuvant chemotherapy (correlation coefficients: 0.42, 0.42, and 0.41, respectively), with an accuracy of ±1 cm in 66% of patients by physical examination, 75% by ultrasonography, and 70% by mammography. Kappa values (0.24–0.35) indicated poor agreement between clinical and pathologic measurements. Conclusion: Physical examination, ultrasonography, and mammography were only moderately useful for predicting residual pathologic tumor size after neoadjuvant chemotherapy. Measurement of tumor size after neoadjuvant chemotherapy for breast cancer is an important part of clinical practice, both for assessing tumor response and for planning surgical resection. We examined the accuracy of physical examination, ultrasonography, and mammography in predicting residual tumor size following neoadjuvant chemotherapy in 189 breast cancer patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/01.sla.0000197714.14318.6f

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 245

Metadata

Authors
Chagpar, A. B., Middleton, L. P., Sahin, A. A., Dempsey, P., Buzdar, A. U., Mirza, A. N., Ames, F. C., Babiera, G. V., Feig, B. W., Hunt, K. K., Kuerer, H. M., Meric-Bernstam, F., Ross, M. I., & Singletary, S. E.
Venue
Annals of Surgery
Published
2006-02
Volume
243
Issue
2
Pages
257-264
ISSN
0003-4932 (ISSN-L)
OpenAlex
W2026981776
Cited by
245
References
0
FWCI
4.35
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Accuracy of Physical Examination, Ultrasonography, and Mammography in Predicting Residual Pathologic Tumor Size in Patients Treated With Neoadjuvant Chemotherapy. https://app.cochat.ai/papers/10.1097/01.sla.0000197714.14318.6f
The paper
Chagpar, A. B., Middleton, L. P., Sahin, A. A., Dempsey, P., Buzdar, A. U., Mirza, A. N., Ames, F. C., Babiera, G. V., Feig, B. W., Hunt, K. K., Kuerer, H. M., Meric-Bernstam, F., Ross, M. I., & Singletary, S. E. (2006). Accuracy of Physical Examination, Ultrasonography, and Mammography in Predicting Residual Pathologic Tumor Size in Patients Treated With Neoadjuvant Chemotherapy. Annals of Surgery. https://doi.org/10.1097/01.sla.0000197714.14318.6f

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.